Cefexy-CV (Cefixime 200 mg + Clavulanic Acid 125 mg Tablets)

Overview:

CEFEXY-CV Tablet contains Cefixime Trihydrate and Clavulanic Acid. Cefixime which possesses excellent efficacy against a broad spectrum of pathogens, including Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis. It is important first-line choice against common bacterial infections.

box-cefexy-CV

Cefixime Trihydrate is a third generation Cephalosporin. Clavulanic acid is a beta-lactamase inhibitor.
It is an antibacterial.

CEFEXY-CV Tablets can be used in the treatment of the following conditions:

  • Pharyngitis, Tonsillitis, Otitis Media
  • Uncomplicated community-acquired pneumonia and infections by non-Ampc ESBL.
  • Acute Bronchitis and Acute exacerbations of chronic bronchitis
  • Uncomplicated Urinary Tract Infections
  • Uncomplicated ano-genital gonorrhea.


Adults and children over 10 years:
One CEFEXY-CV Tablet twice daily. Duration of treatment is 7-14 days.

Cefixime inhibits cell wall synthesis. It binds to one of the penicillin binding proteins (PBPs) which inhibits the final transpeptidation step of the peptidoglycan synthesis in the bacterial cell wall. Clavulanic acid competitively and irreversibly inhibits a wide variety of beta-lactamases, commonly found in microorganisms resistant to penicillins and cephalosporins. Binding and irreversibly inhibiting the beta-lactamase results in a restoration of the antimicrobial activity of beta-lactam antibiotics against lactamase-secreting-resistant bacteria. By inactivating beta-lactamase, the accompanying cephalosporin Cefixime may be made more potent.